PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)

被引：0
|
作者：
KANTARJIAN, H [1 ]
SMITH, T [1 ]
OBRIEN, S [1 ]
ROBERTSON, L [1 ]
KOLLER, C [1 ]
BERAN, M [1 ]
KEATING, M [1 ]
TALPAZ, M [1 ]
机构：
[1] MD ANDERSON CANC CTR,HOUSTON,TX
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A378 / A378
页数：1
相关论文
共 50 条
  • [1] Early treatment decisions with interferon alpha (IFN-A) therapy in early chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, K
    Smith, T
    OBrien, S
    Pierce, S
    Kornblau, S
    Beran, M
    Keating, M
    Talpaz, M
    BLOOD, 1997, 90 (10) : 2303 - 2303
  • [2] COMBINED MODALITY THERAPY WITH INTENSIVE CHEMOTHERAPY (DOAP) FOLLOWED BY ALPHA-INTERFERON (IFN-A) MAINTENANCE IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, HM
    TALPAZ, M
    KEATING, MJ
    WALTERS, RS
    MCCREDIE, KB
    FREIREICH, EJ
    GUTTERMAN, JU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 210 - 210
  • [3] Effect of interferon-alpha (IFN-A) therapy on bone marrow (BM) fibrosis in chronic myelogenous leukemia (CML)
    Wilhelm, M
    Ramos, CM
    OBrien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3537 - 3537
  • [4] CHRONIC MYELOGENOUS LEUKEMIA - CELL-CULTURES AFTER THERAPY WITH ALPHA-INTERFERON - (CML)
    CASTAGNOLA, C
    BONFICHI, M
    MORRA, E
    BRERA, C
    BERNASCONI, P
    LAZZARINO, M
    BERNASCONI, C
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 782 - 782
  • [5] ALPHA-INTERFERON IN CHRONIC MYELOGENOUS LEUKEMIA
    KUMAR, L
    GULATI, SC
    LANCET, 1995, 346 (8981): : 984 - 986
  • [6] ALPHA-INTERFERON AND CHRONIC MYELOGENOUS LEUKEMIA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (16): : 2137 - 2140
  • [7] Improvement of cytogenetic response by GM-CSF in chronic myelogenous leukemia (CML) patients previously treated by interferon-alpha (IFN-A) therapy.
    Belhabri, A
    Thiebaut, A
    Thomas, X
    Charrin, C
    Michallet, M
    BLOOD, 2000, 96 (11) : 252B - 253B
  • [8] Interferon alpha (IFN) and cyclic intensive chemotherapy (CIC) for chronic phase (CP) chronic myelogenous leukemia (CML).
    Giles, FJ
    Talpaz, M
    O'Brien, SM
    Rios, MB
    Kantarjian, HM
    BLOOD, 1999, 94 (10) : 274B - 274B
  • [9] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    BLOOD, 1999, 94 (10) : 279B - 279B
  • [10] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY ALPHA-INTERFERON
    GUILHOT, F
    M S-MEDECINE SCIENCES, 1991, 7 (05): : 453 - 459
12345